We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

034020:KRXDoosan Enerbility Co., Ltd. Analysis

Data as of 2026-07-14 - not real-time

₩70,900.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Doosan Enerbility is trading well below its 20‑day, 50‑day and 200‑day moving averages, with an RSI hovering just above the oversold threshold and a bearish MACD histogram, suggesting short‑term price weakness but also a potential technical bounce. Fundamentally, the company posts solid top‑line growth of roughly 14% YoY, yet margins are razor‑thin and earnings are essentially negative, driving a forward P/E that dwarfs the industry average. The balance sheet shows a high debt‑to‑equity ratio and net cash shortfall, while cash flow remains positive but modest. Market sentiment is at an extreme greed level, which together with a 30‑day volatility near 78% and a beta above 1.5 points to heightened risk.
Given these dynamics, the stock appears overvalued on a earnings basis, with limited upside from its current price relative to analysts' targets. The lack of dividend and weak profitability further diminish its attractiveness for income‑focused investors, while the high leverage and sector cyclicality amplify long‑run uncertainty. Investors should weigh the short‑term technical oversold condition against the structural earnings challenges before deciding on exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Technical oversold signals (RSI ~31, price below all SMAs)
  • Potential short‑term reversal on decreasing volume
  • Support level near 68,200 KRW offering downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth but persistently thin margins
  • High leverage and elevated forward P/E relative to peers
  • Continued sector cyclicality and moderate regulatory exposure

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained low profitability and negative earnings
  • High debt burden limiting financial flexibility
  • Overvaluation combined with high beta and volatility

Key Metrics & Analysis

Financial Health

Revenue Growth13.70%
Profit Margin0.88%
P/E Ratio73.4
ROE2.37%
ROA1.80%
Debt/Equity56.51
Op. Cash Flow₩758.3B
Free Cash Flow₩119.4B
Industry P/E31.0

Technical Analysis

TrendNeutral
RSI31.5
Support₩68,200.00
Resistance₩109,300.00
MA 20₩85,780.00
MA 50₩99,842.00
MA 200₩91,089.50
MACDBearish
VolumeDecreasing
Fear & Greed Index90.68

Valuation

Target Price₩140,478.70
Upside/Downside98.14%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.50
Volatility77.80%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.